V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund 13F holdings
Dodge & Cox Stock Fund's Portfolio
- Portfolio value:
- $114.59B≈
- # of securities:
- 91
- Reported for:
- 31 Mar 2026 (Q1)
- Latest filing date:
- 01 Jun 2026
What stocks does Dodge & Cox Stock Fund own?
What is Dodge & Cox Stock Fund's portfolio?
Dodge & Cox Stock Fund has disclosed a total of 91 security holdings in their (2026 Q1) SEC filing(s) with portfolio value of $114,590,781,738.
Dodge & Cox Stock Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Dodge & Cox Stock Fund's original SEC reports (2026 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
87 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
4.21%
|
51,357,235
|
$93.98
|
+11.94%($105.20)
|
$4,826,552,945
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-1.66% (-867.9K)
|
-0.07%
|
|
|
|
RTX Corp
|
4.06%
|
24,122,000
|
$192.90
|
+11.50%($215.08)
|
$4,653,133,800
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-4.30% (-1.08M)
|
-0.17%
|
|
|
|
Johnson Controls International PLC
|
3.22%
|
28,178,817
|
$130.95
|
+11.93%($146.58)
|
$3,690,016,086
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-5.02% (-1.49M)
|
-0.16%
|
|
|
|
Occidental Petroleum Corp
|
2.87%
|
50,637,640
|
$65.00
|
-13.03%($56.53)
|
$3,291,446,600
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-7.42% (-4.06M)
|
-0.22%
|
|
|
|
TAIWAN SEMICONDUCTOR MANUFAC
|
2.49%
|
50,667,700
|
$56.38
|
-69.42%($17.24)
|
$2,856,413,728
|
2025 Q1
|
≈ 1.25 years
|
Common Stock
|
-1.54% (-791.3K)
|
-0.04%
|
|
|
|
Microsoft Corp
|
2.47%
|
7,653,900
|
$370.17
|
+24.58%($461.18)
|
$2,833,244,163
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
+66.74% (+3.06M)
|
+0.99%
|
|
|
|
MetLife Inc
|
2.32%
|
37,597,542
|
$70.72
|
+36.89%($96.81)
|
$2,658,898,170
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-1.68% (-641.38K)
|
-0.04%
|
|
|
|
Gilead Sciences Inc
|
2.20%
|
18,093,312
|
$139.37
|
-6.49%($130.33)
|
$2,521,664,893
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-7.24% (-1.41M)
|
-0.16%
|
|
|
|
FedEx Corp
|
2.16%
|
6,945,911
|
$356.18
|
-13.37%($308.56)
|
$2,473,994,580
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-34.22% (-3.61M)
|
-1.08%
|
|
|
|
CVS Health Corp
|
2.12%
|
33,887,094
|
$71.82
|
+46.57%($105.26)
|
$2,433,771,091
|
2019 Q3
|
≈ 6.75 years
|
Common Stock
|
-19.30% (-8.1M)
|
-0.49%
|
|
Completely sold out
2 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
ASHTEAD GROUP PLC
|
-26,496,300
|
-1.51%
|
2024 Q2
|
≈ 1.75 years
|
|
|
|
IDEX Corp
|
-771,131
|
-0.11%
|
2025 Q3
|
≈ 0.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.